Clinical Trial Update: Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating tandem autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Systemic Amyloidosis

Snippet

Sponsor: Boston Medical Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED